Purchase Order 75N93020P01248

The U.S. Food and Drug Administration (FDA) awarded an $272.4K firm fixed-price purchase order to Antibody Solutions for the production of monoclonal antibodies production clones. The contract, designated as a Total Small Business set-aside, was awarded on August 1, 2024, with an ultimate completion date of July 31, 2029. Performance will take place at the contractor's facility in Santa Clara, California. This procurement supports the FDA's regulatory and scientific mission, as monoclonal...

This firm fixed price purchase order was awarded by the National Institutes of Health National Cancer Institute to Genscript USA Inc. for $30,280. The contract is for the acquisition of recombinant antibody against mouse ErbB2 (HER2) domain IV via custom protein production services. Specifically, Genscript will immunize rabbits with the antigen protein, collect B cell clones to screen for binding to mouse HER2, collect supernatants from 20 antibody clones, and produce and purify the...

This federal contract award, valued at $3,869.87, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the procurement of mouse antibodies, which are likely to support various biomedical research and public health initiatives at NIAID and other agencies within the Department of Health and Human Services (HHS)....

This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...

Government Scientific Source Inc., a small business laboratory supplier based in Reston, Virginia, has been awarded a $2,533.50 fixed-price delivery order for mouse antibodies (1F5 7ML predilute) by the Defense Department's Medical Supply Chain organization. The contract, awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, will be performed in Herndon, Virginia. This delivery order does not include a set-aside designation and features economic price adjustment...

This firm-fixed price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $9,750 contract is for the delivery of monoclonal antibodies. Precision Antibody is a for-profit manufacturer of goods that specializes in custom antibody development services to support biomedical research. The company has an extensive history of...

This is a $4,565 firm fixed price purchase order awarded to Envigo Bioproducts Inc. by the National Institute of Allergy and Infectious Diseases, a component of the U.S. Department of Health and Human Services. The contract is for the provision of 30 nude mice for antibody production. No set-aside designation was used. Envigo Bioproducts Inc. is a discovery and development contract research organization that has previously provided specialized biomedical products and services, including mice, to...

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ingenious Targeting Laboratory Inc. The contract is valued at $31,245.00 and has a completion date of December 31, 2013. The contract is for the provision of ROSA26 knock-in mice, which are genetically modified mouse models used in biomedical research. The contract was set aside for small businesses, and Ingenious...

The U.S. Defense Health Agency awarded a $34,225 firm-fixed-price delivery order contract to Leinco Technologies, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of monoclonal antibodies from knockout mice that have been in-vivo genetically immunized with interferon-alpha/beta receptor alpha chain protein. This contract award supports federal research initiatives related to COVID-19 and other viral pathogens. Leinco Technologies...